Prescription drug · BLA
Novarel (Gonadotrophin, chorionic) NDC 55566-1502
Kit · Ferring Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55566-1502-1 | 55566150201 | 1 KIT in 1 CARTON (55566-1502-1) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL * 10 mL in 1 VIAL (55566-1700-0)Marketed from Aug 30, 2017 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Novarel
- Generic name (nonproprietary)
- gonadotrophin, chorionic
- Dosage form
- Kit
- Labeler
- Ferring Pharmaceuticals Inc.NDC labeler code 55566
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 017016
- Marketing start
- Listing expires
- Identifiers
- Product ID 55566-1502_dd63b1fd-1f0b-496b-b825-b1f8fb351dbbSPL ID dd63b1fd-1f0b-496b-b825-b1f8fb351dbbSPL set ID ac6918ff-9dc3-40d9-8619-54b26e4bdfc8RxCUI 310587, 1865295
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N455566150201followed by a unit qualifier and the quantityPackage 55566-1502-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY. THERE IS NO SUBSTANTIAL EVIDENCE THAT IT INCREASES WEIGHT LOSS BEYOND THAT RESULTING FROM CALORIC RESTRICTION, THAT IT CAUSES A MORE ATTRACTIVE OR "NORMAL" DISTRIBUTION OF FAT, OR THAT IT DECREASES THE HUNGER AND DISCOMFORT ASSOCIATED WITH CALORIE-RESTRICTED DIETS. Prepubertal cryptorchidism not due to anatomic obstruction. In general, HCG is thought to induce testicular descent in situations when descent would have occurred at puberty. HCG thus may help to predict whether or not orchiopexy will be needed in the future. Although, in some cases, descent following HCG administrat…
Excerpt only. Read the full label for complete information.
About NDC 55566-1502
- What is NDC 55566-1502?
- 55566-1502 is the product NDC for Novarel kit, listed with the FDA by Ferring Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Novarel (Gonadotrophin, chorionic).
- Who is the labeler?
- Ferring Pharmaceuticals Inc., NDC labeler code 55566. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Novarel?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.